Actively Recruiting
Virological and Immunological Determinants of Arbovirus Infection in New Caledonia
Led by Institut Pasteur · Updated on 2024-05-23
250
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
Sponsors
I
Institut Pasteur
Lead Sponsor
I
Institut Pasteur de Nouvelle-Calédonie
Collaborating Sponsor
AI-Summary
What this Trial Is About
Arboviruses, diseases transmitted to humans by the bite of an insect vector, are a major public health problem, particularly in tropical and sub-tropical countries. In New Caledonia, dengue epidemics are recurrent and may be associated with the co-circulation of other arboviruses such as Zika or chikungunya. The virological determinants which condition the occurrence of these epidemics may be linked to an increased vectorial competence of the vector mosquito Aedes aegypti for a particular viral isolate. In fact, the Aedes aegypti mosquito is infected by making a blood meal on a person infected with an arbovirus. The virus infects its digestive tract, then spreads throughout the mosquito's body until it reaches its salivary glands. The virus is then present in the saliva and will be injected into the human host during a new blood meal. Some viral variants are best transmitted by Aedes aegypti. In general, the study of this vectorial competence is carried out by experiments in the laboratory during which an artificial blood meal composed of mammalian blood (human, rabbit, etc.) is mixed with a viral stock. Carrying out deported blood meals during which blood collected from patients infected with an arbovirus is used to gorge mosquitoes makes it possible to place oneself in experimental conditions as close as possible to the natural cycle of transmission of arboviruses. In the human host, cells of the myeloid lineage present in the peripheral blood constitute preferred targets of replication for arboviruses. At the same time, the peripheral blood cells of patients are activated in response to infection and secrete many soluble factors released into the blood of patients. The study of blood samples from patients infected with arboviruses is therefore of prime importance for understanding both the replicative mechanisms of arboviruses but also the immune response they induce.
CONDITIONS
Official Title
Virological and Immunological Determinants of Arbovirus Infection in New Caledonia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patient
- Patient showing clinical signs suggestive of an arbovirus infection, including fever and at least two symptoms such as muscle pain, retro-orbital pain, low platelets (if available), digestive symptoms
- Symptoms started within 7 days prior to blood sample collection
- Patient informed about the study and biological sample collection
- Patient has given consent for data collection and use of an additional blood sample
You will not qualify if you...
- Patient with another known viral infection, inflammatory disease, or using anti-inflammatory drugs
- Pregnant patient
- Patient who traveled abroad within 15 days before symptoms began
- Incomplete or unavailable blood sample
- Patient condition deemed unsuitable by the doctor for the additional blood sample
- Patient who has not consented to participate in the research
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre Hospitalier Territorial de Nouvelle-Calédonie
Dumbéa Sur Mer, New Caledonia
Actively Recruiting
Research Team
M
Myrielle Dupont-Rouzeyrol, PhD
CONTACT
C
Catherine Inizan, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here